CLINICAL_TRIALS
trial_result
· 2017-03-03
Clinical Trial Update: Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis [EARLY_Phase 1]
Summary
This update reports the completion of an early-phase pilot trial testing arsenic trioxide in combination with cytarabine for myelofibrosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Weill Medical College of Cornell University | Conditions: Myelofibrosis | EARLY_Phase 1 | Status: COMPLETED